Osteosarcoma: The COSS Experience-Reference-Cited by-同舟云学术

Osteosarcoma: The COSS Experience

Published:2009 Issue: Volume: Page:289-308
ISSN:0927-3042
Container-title:Cancer Treatment and Research
language:
Short-container-title:

Author:

Bielack Stefan,Jürgens Herbert,Jundt Gernot,Kevric Matthias,Kühne Thomas,Reichardt Peter,Zoubek Andreas,Werner Mathias,Winkelmann Winfried,Kotz Rainer

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4419-0284-9_15.pdf

Reference37 articles.

1. Winkler K, Beron G, Schellong G, et al. Kooperative Osteosarkomstudie COSS-77: Ergebnisse nach über 4 Jahren. Klin Pädiatr. 1982;194:251-256.

2. Winkler K, Beron G, Kotz R, et al. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a cooperative German/Austrian study. J Clin Oncol. 1984;2:617-623.

3. Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol. 1988;6:329-337.

4. Bielack S, Beck J, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years. Klin Padiatr. 1989;201:275-284.

5. Winkler K, Bielack S, Delling G, et al. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer. 1990;66:1703-1710.

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 9-O-monoethyl succinate berberine effectively blocks the PI3K/AKT signaling pathway by targeting Wnt5a protein in inhibiting osteosarcoma growth;Phytomedicine;2024-09

2. The prognostic value of ubiquitin/ubiquitin-like-related genes along with immune cell infiltration and clinicopathological features in osteosarcoma;Journal of Orthopaedic Surgery and Research;2024-06-15

3. Identification of hub genes related to metastasis and prognosis of osteosarcoma and establishment of a prognostic model with bioinformatic methods;Medicine;2024-06-07

4. Osteosarcomas in retinoblastoma-survivors. A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS);EJC Paediatric Oncology;2024-06

5. Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS);Cancers;2024-05-11